Menopausal women with metabolic syndrome before starting hormone therapy had a 2-fold greater risk for heart attack or dying of heart disease. Metabolic syndrome is classified as those with 3/5 of the following symptoms: Increased abdominal fat, insulin resistance, blood pressure above 130/85mmHg, low HDL and high triglyceride levels.